c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells

Kun Wu1, Yan Zhao, Gui-Chang Li

  • 1Department of Nutrition and Food Hygiene, Public Health School, Harbin Medical University, Harbin 150001, Heilongjiang Province, China. wukun@public.hr.hl.cn

Abstract

Insights

Vitamin E succinate (VES) induces apoptosis in gastric cancer cells by activating the c-Jun N-terminal kinase (JNK) pathway. This pathway involves c-Jun, highlighting a potential therapeutic target for gastric cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Gastric cancer remains a significant global health challenge.
  • Identifying novel therapeutic agents and understanding their mechanisms of action are crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of the c-Jun N-terminal kinase (JNK) signaling pathway in vitamin E succinate (VES)-induced apoptosis.
  • To elucidate the molecular mechanisms by which VES triggers cell death in human gastric cancer SGC-7901 cells.

Main Methods:

  • Human gastric cancer SGC-7901 cells were treated with varying concentrations of VES.
  • Apoptosis was assessed using DAPI staining and DNA fragmentation assays.
  • Western blot analysis was employed to measure JNK and phosphorylated JNK (p-JNK) expression.
  • The impact of dominant-negative JNK (DN-JNK) transfection on VES-induced apoptosis and c-Jun expression was evaluated.

Main Results:

  • VES treatment induced significant DNA fragmentation, indicative of apoptosis, in a dose-dependent manner.
  • VES markedly increased the phosphorylation of JNK, with a sustained elevation observed over 24 hours.
  • Transfection with DN-JNK partially blocked VES-induced apoptosis and modulated JNK and c-Jun protein levels.

Conclusions:

  • The JNK signaling pathway plays a critical role in VES-induced apoptosis in human gastric cancer cells.
  • VES-induced apoptosis is mediated through the JNK pathway, involving c-Jun and its downstream targets.
  • These findings suggest that VES and the JNK pathway represent a promising therapeutic strategy for gastric cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...